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Abstract: This study was undertaken to determine the influences of various doses of peppermint oil on the hepatic en-
zymes, alanine transaminase, apartate tranaminase, alkaline phosphotase and gamma glutamyl transferase and the level of 
malondialdehyde in the serum of mice with and without immobility stress. The mice exposed to drink water, 0.9, 27 and 
60 mg/kg peppermint oil from the days 1 to 5 for a period of 4 h before and after immobility stress. Serum MDA in-
creased in treatment group II, III and IV after immobility stress. There was a significant decrease in ALT in treatment 
group III and IV after immobility stress. There were also significant decreases in ALP and GGT in treatment group IV af-
ter immobility stress. This result may suggest that, MDA level is higher in immobilization stress group than in the un-
immobilized animals in serum and this results show that enzyme activities decreased after immobilization stress. 
Keywords: Peppermint oil, lipid peroxidation, hepatic enzymes, immobility stress. 
INTRODUCTION 
 The currently observed rapid increase in consumption of 
herbal remedies worldwide has been stimulated by several 
factors, including the notion that all herbal products are safe 
and effective [1-3]. However, over the past decade, several 
news-catching episodes in developed communities indicated 
adverse effects, sometimes life-threatening, allegedly arising 
consequential to taking herbal products or traditional medi-
cines from various ethnic groups [4, 5]. In some cases, adul-
teration, inappropriate formulation, or lack of understanding 
of plant and drug interactions or uses has led to adverse reac-
tions that are sometimes life-threatening or lethal to patients 
[6-8]. Peppermint (Mentha piperita L.) is a perennial herb 
native to Europe, naturalized in the northern USA and Cana-
da, and cultivated in many parts of the world. A hybrid of 
spearmint (M spicafa L.) and water mint (M. aquatica L.), 
peppermint grows particularly well in areas with high water-
holding capacity soil. Peppermint leaves (fresh and dried) 
and the essential oil extracted from the leaves are used in 
many foods, cosmetic and pharmaceutical products. The 
chemical components of peppermint leaves and oil vary with 
plant maturity, variety, geographical region and processing 
conditions [9-13]. About 80% of the world population cur-
rently relies on indigenous or traditional medicines for their 
primary health needs, and most of this therapy involves the 
use of plant extracts, often in aqueous solutions [14]. Of the 
plant-based foods used as medicines, none have received 
more attention as a group than herbal remedies [15]. The use 
of herbal preparations, typically prepared by steeping or 
heating crude plant material, has prevailed for centuries and 
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healthcare providers in Europe and Asia today often pre-
scribe herbal teas. However, such practices are largely based 
on folklore and schools of traditional medicine rather than 
evidence-based research. A large and increasing percentage 
of people consume herbal medicines and there is a universal-
ly acknowledged need for more studies of adverse effects, 
including liver toxicity [16]. Peppermint oil has been used 
externally (e.g. for insect bites). However, it is also adminis-
tered orally for the treatment of irritable bowel syndrome 
[17]. Peppermint oil consists of many components, with 
menthol being a major constituent. Most reports of toxic 
effects due to the use of herbal medicines and dietary sup-
plements are associated with hepatotoxicity has been pub-
lished in medical literature. On the basis of various case 
reports, liver injury from herbal remedies has ranged from 
mild elevations of liver enzymes to fulminated liver failure 
[18]. The effects of components of peppermint oil have been 
investigated in rats [19, 20] that were administrated menthol 
or menthone (200-800 mg/kg) for 28 days. Histopathological 
liver changes and changes in liver function were found in 
those studies. Lipid peroxidation has damaging effects on 
liver cell membrane. The extent of lipid peroxidation was 
measured using a technique based on the thiobarbituric acid 
reactive substance (TBARS) assay that detects malondialde-
hyde (MDA), an end product of peroxidative decomposition 
of polyeonic fatty acids in in vitro systems [21]. The purpose 
of this study was to examine the effect of peppermint oil on 
the activity of several liver enzymes and serum MDA in 
male albino rats, under normal conditions and during stress 
(immobilization). This is a relatively straight forward exper-
imental study. 
MATERIALS AND METHODOLOGY 
 The study was performed in 2010 on forty–eight male 
albino mice weighing 27.30-28.30 g of 3–4 postnatal weeks 
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(provided from the Iranian Pasteur Institute) in the Faculty of 
Medicine, Biochemistry and Metabolic Disorder Research 
Center, Gorgan University of Medical Sciences. The animals 
were kept in special cages, with standard dimension in a 
room with 12 h rotation of being in light and darkness at 
20±2 º C, till the time of experiment. The animals were al-
lowed to have drinking water and prepared food (Dam Pars 
Production), and they went only once under experimental 
procedure. 0.5 ml peppermint oil was injected to animals 
every day at 8.30 AM. Peppermint oil is purchased form 
Barij Essence Pharmaceutical Co., Kashan, Iran. Alcoholic 
extract of Barij peppermint contained 50% of mentol, men-
ton and mentol acetate. To dilute the peppermint extract, 
physiological saline was used as carrier. Different concentra-
tion of peppermint extracts were chosen on the bases of pilot 
tests. The animals were divided into 8 groups of 10 mice. 
The mice were randomly divided into two equal groups on 
the basis of the differences in the concentrations of pepper-
mint oil. Each group was subdivided into four on the basis of 
drinking water, 0.9, 27 and 60 mg/kg peppermint oil, as 
follows: 
Without Immobility Stress 
 Treatment Group (Group I) received only drinking water, 
Treatment Group (Group II) received 0.9 mg/kg peppermint 
oil, Treatment Group (Group III) received 27 mg/kg pep-
permint oil, Treatment Group (Group IV) received 60 mg/kg 
peppermint oil. 
Under Immobility Stress 
 Treatment Group (Group I) received only drinking water, 
Treatment Group (Group II) received 0.9 mg/kg peppermint 
oil, Treatment Group (Group III) received 27 mg/kg pep-
permint oil, Treatment Group (Group IV) received 60 mg/kg 
peppermint oil. 
 It was found by means of a digital scale that the mean 
weight for each group was 27.75±0.31 gr (I), 27.85±0.32 gr 
(II), 27.89±0.30 (III) and 27.84±0.35 gr (IV). The experi-
mental groups were exposed to immobility stress every 
morning from the days 1 to 5 for a period of 4 h. The immo-
bility stress was produced by plastic tubes (self made) with 
length and width of 15 cm, 15 cm respectively, and while in 
the tube, the animals was able to breathe smoothly and 
properly and were under no physical strain. The animals 
prior to surgery made unconscious by the combination of 
ketamine 10% (100 mg/kg) and xylazine 2% (10 mg/kg) 
which were injected through peritoneum. At the end of the 
5th day of the experiment, the thorax of the mice was opened 
and 2-3 ml of blood was collected from the heart of each 
mouse under anesthesia. The blood samples were centrifuged 
at 3000 rpm for 10 min after waiting for 10 min after waiting 
15 min at room temperature. Serum was collected and stored 
at -20º C. The time of experiments was between 10 am – 3 
pm each day. Serum lipid peroxidation (expressed as 
malondialdehyde) examined by Satoh method [22] and he-
patic enzymes ALT, AST, ALP and GGT examined by 
Commercial laboratory kits [23-25] and using specteropho-
tometry and photometry techniques in Biochemistry and 
Metabolic Disorder Research Center. Experimental results 
concerning this study were evaluated by using SPSS v.16 
and expressed as Mean± SD. Also independent and paired t-
test and ANOVA Post-huc was performed to determine the 
difference between groups. P<0.05 was considered signifi-
cant. 
RESULTS  
 Findings of serum MDA, ALT, AST, GGT and ALP are 
reported in Tables 1 and 2. Table 1 and 2 contain mean ± SD 
of MDA, ALT, AST, ALP and GGT values for mice exposed 
to drink water, 0.9, 27 and 60 mg/kg peppermint oil from the 
days 1 to 5 for a period of 4 h before and after immobility 
stress. Table 1 shows (before immobility stress) that the 
mean value of serum MDA and ALP decreased and serum 
ALT, AST and GGT increased in comparison with treatment 
group I. There was significant decreases in MDA in treat-
ment group III when compared with treatment group I 
(p=0.005). There was also significant decreases in MDA in 
treatment group IV when compared with treatment group I, 
II and III (p<0.001).There was significant decreases in ALP 
in treatment group IV when compared with treatment group I 
(p=0.020) and there was significant increases in AST in 
treatment group III and IV when compared with treatment 
group I (p=0.001) and II (p<0.001).There was no significant 
difference in ALT and GGT in all treatment groups (Table 
1). Table 2 shows (after immobility stress) that the mean of 
serum MDA, ALT and ALP decreased and serum AST and 
GGT increased in comparison with treatment group I. There 
was significant decreases in MDA in treatment group IV 
when compared with treatment groups I (p=0.001), II 
(p=0.006) and III (p=0.024) and significant decreases in ALP 
when compared with treatment group I (P=0.030). There was 
significant increases in AST in treatment group III and IV 
when compared with treatment group I (p= 0.032 and 
p=0.001) respectively. There was no significant difference in 
ALT and GGT in all treatment groups (Table 2). Table 3 
shows the comparison of serum MDA levels and hepatic 
enzymes before and after immobility stress. The mean of 
serum MDA significantly increased in treatment group II, III 
and IV after immobility stress (P=0.026, P=0.001 and 
P<0.001 respectively). There was significant decreases in 
ALT in treatment group III and IV after immobility stress 
(p=0.001 and p<0.001 respectively). There were also signifi-
cant decrease in ALP and GGT in treatment group IV after 
immobility stress (p=0.011 and p=0.011 respectively).There 
was no significant difference in all other treatment groups. 
DISCUSSION AND CONCLUSION  
 The results of this study indicate that there has been low-
er MDA production during peppermint oil metabolism so 
that even the increase in AST, ALT and GGT activities could 
eliminate the MDA. A significant decrease in MDA level in 
treatment group III and IV also supported this idea. The 
study revealed that MDA levels were found to have de-
creased during the use of higher doses of peppermint oil (27 
and 60 mg/kg) and the low amounts of MDA have not been 
shown to inhibit the activities of AST, ALT and GGT, 
whereas there have been changes in ALP activity which were 
given 60 mg/kg peppermint oil. The data we have interpreted 
as a low amount of MDA formation could be eliminated with 
the use of higher doses of peppermint oil (27 and 60 mg/kg). 
These results indicate that low levels of MDA formation 
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Table 1. Serum levels of Alanine Transaminase (ALT), Apartate Tranaminase (AST), Alkaline Phosphotase (ALP) and Gamma 
Glutamyl Transferase (GGT) in Treatment Groups Without Immobility Stress 
GGT (IU/L) ALP (IU/L) AST (IU/L) ALT (IU/L) MDA (nmol/ml) Groups 
13..04±4.93 155.20±37.12 89.10±28.12 95.20±36.90 1.91±0.20 Treatment Group I 
15.42±8.35 132.20±18.50 90.40±27.50 115.85±40.79 1.85±0.08 Treatment Group II 
17.43±7.59 129.0±36.54 136.60±12.98 3 121.20±31.18 1.70±0.07 1 Treatment Group III 
18.99±6.51 116.60±10.66 5 157.20±28.79 4 127.50±36.76 1.40±0.13 2 Treatment Group IV 
Values are means ± SD. Calculated from n=10 in each group.,1 p =0.005 compared to treatment Group I (control group) (ANOVA), 2p <0.001 compared to treatment Group I (control 
group), II and III (ANOVA), 3 p =0.001 and 4 p <0.001 compared to treatment Group I (control group) and II (ANOVA), 5 p =0.020 compared to treatment Group I (ANOVA), 
Treatment Group I (TG I) received drink water daily for 5 day (control group)., Treatment Group II (TG II) received 0.9 mg/kg peppermint oil daily for 5 days, Treatment Group III 
(TG III) received 27 mg/kg peppermint oil daily for 5 day, Treatment Group IV (TG IV) received 60 mg/kg peppermint oil daily for 5 day. 
 
Table 2. Serum Levels of Alanine Transaminase (ALT), Apartate Tranaminase (AST), Alkaline Phosphotase (ALP) and Gamma 
Glutamyl Transferase (GGT) in Treatment Groups with Immobility Stress 
GGT (IU/L) ALP (IU/L) AST (IU/L) ALT (IU/L) MDA (nmol/ml) Groups 
10.61±4.19 135.60±41.04 76.60±22.48 104.20±61.91 2.13±0.40 Treatment Group I 
12.41±5.35 120.0±30.42 102.0±13.98 99.80±29.50 2.05±0.24 Treatment Group II 
12.71±4.59 103.10±37.60 123.30±37.89 3 75.10±19.16 1.98±0.22 Treatment Group III 
12.81±4.09 90.80±26.88 4 143.0±55.92 2 61.30±20.38 1.63±0.09 1 Treatment Group IV 
Values are means ± SD. Calculated from n=10 in each group, 1p =0.001, 1 p =0.006 and 1 p= 0.024 compared to treatment Group I (control group), II and III (ANOVA), 2 p =0.001and 
4 p =0.030 compared to treatment Group I (control group) (ANOVA), 3 p =0.032 compared to treatment Group I (control group) (ANOVA), Treatment Group I (TG I) received drink 
water daily for 5 day (control group), Treatment Group II (TG II) received 0.9 mg/kg peppermint oil daily for 5 days, Treatment Group III (TG III) received 27 mg/kg peppermint oil 
daily for 5 day, Treatment Group IV (TG IV) received 60 mg/kg peppermint oil daily for 5 day. 
 
Table 3. Comparison of Serum Alanine Transaminase (ALT), Apartate Tranaminase (AST), Alkaline Phosphotase (ALP) and Gam-
ma Glutamyl Transferase (GGT) in Treatment Groups Pre- and Post- Immobility Stress 
 T G I  
Pre- IS  
T G I  
Post- IS 
T G II 
 Pre- IS  
T G II  
Post- IS  
T G III  
Pre- IS  
T G III  
Post- IS  
T G IV 
 Pre- IS  
T G IV  
Post- IS  
MDA 
(nmol/ml) 
1.91±0.20 2.13±0.40 1.85±0.08 2.05±0.241 1.70±0.07 1.98±0.222 1.40±0.13 1.63±0.093 
ALT 
(IU/L) 
95.20±36.90 104.20±61.91 115.85±40.79 99.80±29.50 121.20±31.18 75.10±19.164 127.50±36.76 61.30±20.385 
AST 
(IU/L) 
89.10±28.12 76.60±22.48 90.40±27.50 102.0±13.98 136.60±12.98 123.30±37.89 157.20±28.79 143.0±55.92 
ALP 
(IU/L) 
155.20±37.12 135.60±41.04 132.20±18.50 120.0±30.42 129.0±36.54 103.10±37.60 116.60±10.66 90.80±26.886 
GGT 
(IU/L) 
13..04±4.93 10.61±4.19 15.42±8.35 12.41±5.35 17.43±7.59 12.71±4.59 18.99±6.51 12.81±4.097 
Treatment Group I (TG I) received drink water daily for 5 day (control group), Treatment Group II (TG II) received 0.9 mg/kg peppermint oil daily for 5 days, Treatment Group III 
(TG III) received 27 mg/kg peppermint oil daily for 5 day, Treatment Group IV (TG IV) received 60 mg/kg peppermint oil daily for 5 day, IS: immobility stress, 1P=0.026, 2P=0.001, 
3P<0.001, 4p=0.001, 5p<0.001, 6p=0.011 and 7p=0.011. 
during dose-dependent peppermint oil metabolism could not 
inhibit AST, ALT and GGT activities and inhibits the ALP 
activity. There are a number of reports which indicates many 
adverse effects of spearmint to induce oxidative stress [26]. 
It has also been shown to develop severe histopathological 
malformations in liver tissues of rats [27]. According to 
Mimica-Dukic et al., [28], the free radical scavenging capac-
ity of M. piperita oil was high. In their experiment, M. 
piperita reduced the radical generator 2, 2-diphenyl-1-
picrylhydrazyl (DPPH) by 50% and inhibited the generation 
of the OH radical. Rats given daily oral doses of 83 μL/kg 
peppermint oil for 28 days had significantly increased ALP 
level when compared with control group, but no increase in 
GGT or ALT [29]. Menthol administered to rats by gavage 
at 200, 400 and 800 mg/kg for 28 days significantly in-
creased the absolute and relative liver weights and the vacu-
54    The Open Biochemistry Journal, 2012, Volume 6 Marjani et al. 
olization of hepatocytes at all doses, although no sign of 
encephalopathy was observed [30]. Menthone given orally to 
rats at 200, 400 and 800 mg/kg for 28 days increased liver 
weight [19]. In a separate study, forty-eight male Wistar rats 
were used, and peppermint oil solution was prepared and 
daily given to the rats for 30 days as drinking water. Their 
findings showed that liver function tests, including AST and 
ALT activities and thiobarbituric acid reactive substance 
(TBARS) were measured. AST and ALT activities and the 
TBARS level were increased when compared with the con-
trol group. Histopathological evaluation of experimental 
groups revealed a mild to severe degree of hepatic damage 
when compared to the control group [31]. Alkaline phospha-
tase is commonly used as a relatively nonspecific indicator 
of hepatic injury [32, 33]. It is therefore possible that chronic 
treatment with peppermint oil resulted in some degree of 
hepatic impairment, although no other parameters of liver 
function or liver morphology were impaired [30]. It has been 
shown previously that extracts of Mentha piperita (from 
which peppermint oil is derived) can increase ALP activity 
in irradiated rats [34] and that rats administered pulegone (a 
component of peppermint oil) for 28 days had increased 
plasma ALP activity without significant histopathology of 
the liver [28]. A dose-dependent increase in ALP has also 
been shown in rats administered menthone, another compo-
nent of peppermint oil, for 28 days. Components of pepper-
mint oil, namely pulegone (80– 160 mg/kg) and menthol or 
menthone (200–800 mg/kg), administered to rats for 28 days 
have been shown to produce liver histopathological changes 
and changes in liver function [19, 20]. In another study fol-
lowing treatment with peppermint oil resulted in a significant 
increase in ALP levels, but not in GGT or ALT. There were 
no significant changes in liver enzyme activities following 
acute treatment with peppermint oil. However, there were no 
changes in rat liver histology after any of the treatments with 
peppermint oil. In human cultured hepatoma cells, the per-
centage of dead cells was not affected by low concentrations 
(0.05 mL/L) of peppermint oil compared with vehicle con-
trols. However, there was a significant increase in the per-
centage of dead cells with higher concentration of pepper-
mint oil (0.5 mL/L) [22]. Our results are in accordance with 
the previous studies that the serum lipid peroxidation level 
has been decreased [29]. There are several studies, which 
show an increment in serum lipid peroxidation levels [27, 
33]. Our results are also correlated with the previous studies 
that the serum ALT and AST has been increased [25] but our 
findings are not in agreement with other studies [30, 33]. The 
reduction of enzyme activities suggest that immobilization 
stress may increase MDA production in the serum of immo-
bilized mice. Davydov et al., [35] suggested that immobiliza-
tion stress stimulates free radical generation in the liver of 
both adult and old rats. These results indicate that MDA 
levels shown to be higher after immobilization stress than 
before in mice which were given peppermint oil. Lipid pe-
roxidation markers (MDA and TBARS) are known to be 
increased in stress conditions in plasma [36], erythrocyte 
[37-39] and different tissues [40-45] of animals. Our results 
in agreement with previous study [36].The reduction of en-
zyme activities and elevation of MDA suggest that immobi-
lization stress increase MDA production in serum of mice. 
When we compared enzyme activities in higher concentra-
tions of peppermint oil (27 and 60 mg/kg) before and after 
immobilization stress, the significant amount of decreased 
enzyme activities were observed in the serum of mice. This 
result may suggest that, MDA level is higher in immobiliza-
tion stress group than in the un-immobilized animals in se-
rum and this results show that enzyme activities decreased 
after immobilization stress. We may also suggest that gener-
ated MDA may damage enzymes (proteins) that are produce 
in the liver; therefore, it can lower enzyme activity. Immobi-
lization stress can be a model for investigating the alterations 
occurring in liver enzymes. According to our results, expo-
sure to immobilization stress (4 h/day for 5 days) may lead to 
increment of free radical generation which may have 
changed liver enzyme activities, and lipid peroxidation ele-
vation in serum of mice. This result may suggest that, MDA 
level is higher in immobilization stress group than in the un-
immobilized animals in serum and these results also show 
that enzyme activities decreased after immobilization stress. 
Using effective dose of peppermint oil is probably reduces 
the effect of immobilization stress on liver enzymes. Further 
studies are needed to clarify the mechanism of stress-
dependent free radical generation and its effects on the oxi-
dative modifications in different tissues. 
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